3-Methoxy-4-methyl-N,N-dimethylanilin | 56140-36-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-Methoxy-4-methyl-N,N-dimethylanilin
• 英文别名: 3-methoxy-4,N,N-trimethyl-aniline；3-Methoxy-4,N,N-trimethyl-anilin；6-Methyl-N,N-dimethylamino-phenyl-methyl-aether；3-methoxy-N,N,4-trimethylaniline
• CAS: 56140-36-4
• 化学式: C₁₀H₁₅NO
• 分子量: 165.235
• InChiKey: GSKNTTCFZCYCAD-UHFFFAOYSA-N

物化性质

• 沸点：
  88-89 °C(Press: 2 Torr)
• 密度：
  0.985±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-Methoxy-4-methyl-N,N-dimethylanilin 、 sodium methansulfinate 在 dipotassium peroxodisulfate 、 [Ir[2-(2,4-difluorophenyl)-5-trifluoromethylpyridine]₂(4,4′-di-t-Bu-2,2′-bipyridine)]PF₆ 、 四丁基硫酸氢铵 作用下， 以 水 、 乙腈 为溶剂， 反应 72.0h， 生成 5-methoxy-N,N,4-trimethyl-2-methylsulfonylaniline 、
  参考文献：
  名称：

  可见光介导的苯胺直接磺酰化†

  摘要：

  砜在生物活性分子中具有显着特征，并且是有机合成的关键功能基团。我们报告了一个温和的，光氧化还原催化的亚磺酸盐与苯胺衍生物的磺酰化反应，并通过药物的后期功能化证明了该方法的实用性。该方法的主要特点是可以从稳定的亚磺酸盐直接生成磺酰基，并使用简单的苯胺衍生物作为便捷的偶联剂。

  DOI：

  10.1039/c7sc03891g
• 作为产物：
  描述：

  1-溴-2-甲氧基-3-甲基苯 、 lithium dimethylamide 在 乙醚 作用下， 生成 3-Methoxy-4-methyl-N,N-dimethylanilin
  参考文献：
  名称：

  Notes - The Reaction of Haloanisoles with Lithium Dimethylamide

  摘要：

  DOI：

  10.1021/jo01109a602

文献信息

• MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS
  申请人：HADIDA RUAH SARA S.

  公开号：US20090143381A1

  公开（公告）日：2009-06-04

  Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

  本发明的化合物及其药用可接受的组合物可用作ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜传导调节蛋白（“CFTR”）。本发明还涉及使用本发明的化合物治疗ABC转运蛋白介导的疾病的方法。
• METHOD FOR PRODUCING CYANOACETIC ACID, METHOD FOR PRODUCING CYANOACETIC ACID DERIVATIVE AND METHOD FOR PRODUCING METAL CONTAINING COMPOUND
  申请人：IKEMIZU Dai

  公开号：US20130253213A1

  公开（公告）日：2013-09-26

  Provided is a method for producing cyanoacetic acid in a hydrolysis reaction of a predetermined cyanoacetate in the presence of an acid catalyst. Further, are provided methods for producing a cyanoacetic acid derivative and a metal containing compound by using the produced cyanoacetic acid as a staring material. Herein, the method for producing cyanoacetic acid enables the content of a malonic acid byproduct generated in the hydrolysis reaction to be greatly lowered, allowing the produced cyanoacetic acid to be used as a starting material without any purification treatments. Those advantageous effects result in the great improvement in the purity and yields of the cyanoacetic acid derivative and the metal containing compound produced by said cyanoacetic acid. Accordingly, the above mentioned methods make it possible to produce cyanoacetic acid, the cyanoacetic acid derivative and the metal containing compound, as excellent in the productivity and economical efficiency.

  提供了一种在酸催化剂存在下，通过水解预定的氰乙酸盐生成氰乙酸的方法。此外，提供了利用生成的氰乙酸作为起始物质来生产氰乙酸衍生物和含金属化合物的方法。在这种生产氰乙酸的方法中，使得在水解反应中生成的丙二酸副产物的含量大大降低，使得生成的氰乙酸可以作为起始物质而无需任何纯化处理。这些有利效果导致了通过该氰乙酸生成的氰乙酸衍生物和含金属化合物的纯度和产量显著提高。因此，上述方法使得能够以高生产率和经济效益生产氰乙酸、氰乙酸衍生物和含金属化合物。
• SUBSTITUTED BICYCLIC PYRIMIDONE DERIVATIVES
  申请人：CHEREZE Nathalie

  公开号：US20090036427A1

  公开（公告）日：2009-02-05

  A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof: Wherein Y, Z, R1, R2, R3, R4, R5, R6, R7, n, m, and o are as described herein. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β, such as Alzheimer disease.

  一种由式（I）表示的吡啶酮衍生物或其盐、溶剂或水合物：其中Y、Z、R1、R2、R3、R4、R5、R6、R7、n、m和o如所述。本发明还涉及一种药物，其包含所述衍生物或其盐作为活性成分，用于预防和/或治疗由GSK3β异常活性引起的神经退行性疾病，如阿尔茨海默病。
• Modulators of ATP-binding cassette transporters
  申请人：Ruah Sara S. Hadida

  公开号：US20080113985A1

  公开（公告）日：2008-05-15

  Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

  本发明的化合物及其药学上可接受的组合物，可用作ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜传导调节因子（“CFTR”）。本发明还涉及使用本发明的化合物治疗ABC转运蛋白介导的疾病的方法。
• MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
  申请人：Hadida Ruah Sara S.

  公开号：US20080306062A1

  公开（公告）日：2008-12-11

  Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

  本发明的化合物及其药学上可接受的组合物，可用作ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜传导调节因子（“CFTR”）。本发明还涉及使用本发明的化合物治疗ABC转运蛋白介导的疾病的方法。